ado-trastuzumab emtansine (Kadcyla)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ado-trastuzumab emtansine (Kadcyla), covering 2024-09-19 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers [Phase 2]